JPH0572366B2 - - Google Patents

Info

Publication number
JPH0572366B2
JPH0572366B2 JP59086273A JP8627384A JPH0572366B2 JP H0572366 B2 JPH0572366 B2 JP H0572366B2 JP 59086273 A JP59086273 A JP 59086273A JP 8627384 A JP8627384 A JP 8627384A JP H0572366 B2 JPH0572366 B2 JP H0572366B2
Authority
JP
Japan
Prior art keywords
furocoumarin
blood
virus
biological
furocoumarins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP59086273A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6016930A (ja
Inventor
Pii Uiisehan Garii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADOBANSUTO JENETEITSUKUSU RISA
ADOBANSUTO JENETEITSUKUSU RISAACHI INST
Original Assignee
ADOBANSUTO JENETEITSUKUSU RISA
ADOBANSUTO JENETEITSUKUSU RISAACHI INST
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADOBANSUTO JENETEITSUKUSU RISA, ADOBANSUTO JENETEITSUKUSU RISAACHI INST filed Critical ADOBANSUTO JENETEITSUKUSU RISA
Publication of JPS6016930A publication Critical patent/JPS6016930A/ja
Publication of JPH0572366B2 publication Critical patent/JPH0572366B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/02—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using physical phenomena
    • A61L2/08—Radiation
    • A61L2/10—Ultraviolet radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
    • A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Anesthesiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • External Artificial Organs (AREA)
JP59086273A 1983-05-02 1984-05-01 生物学的蛋白質含有組成物の汚染除去法 Granted JPS6016930A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49068183A 1983-05-02 1983-05-02
US490681 1983-05-02

Publications (2)

Publication Number Publication Date
JPS6016930A JPS6016930A (ja) 1985-01-28
JPH0572366B2 true JPH0572366B2 (enExample) 1993-10-12

Family

ID=23949050

Family Applications (1)

Application Number Title Priority Date Filing Date
JP59086273A Granted JPS6016930A (ja) 1983-05-02 1984-05-01 生物学的蛋白質含有組成物の汚染除去法

Country Status (7)

Country Link
EP (1) EP0124363B1 (enExample)
JP (1) JPS6016930A (enExample)
AT (1) ATE59145T1 (enExample)
AU (1) AU563557B2 (enExample)
CA (1) CA1224622A (enExample)
DE (1) DE3483751D1 (enExample)
ZA (1) ZA843270B (enExample)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK507185A (da) * 1984-11-05 1986-05-06 Du Pont Fremgangsmaade til inaktivering af human tumor leukaemi virus iii
JPS61275228A (ja) * 1985-03-14 1986-12-05 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド 治療用タンパク組成物中のビ−ルスの光動的不活性化
US4789545A (en) * 1986-03-31 1988-12-06 New York Blood Center, Inc. Removal of lipid soluble process chemicals from biological materials by extraction with naturally occurring oils or synthetic substitutes thereof
US4775625A (en) * 1986-11-21 1988-10-04 The Medical College Of Wisconsin, Inc. Inactivating enveloped viruses with a merocyanine dye
US4878891A (en) † 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
US5571666A (en) * 1988-10-28 1996-11-05 Oklahoma Medical Research Foundation Thiazine dyes used to inactivate HIV in biological fluids
IL92996A (en) * 1989-01-10 1996-06-18 Bisaccia Emil Photovoltaic compounds as drugs for the treatment of viral infections and a method for the production of vaccines
DE69033116D1 (de) * 1989-10-26 1999-06-24 Stephen T Isaacs Verfahren zur hemmung der enzymatischen herstellung von nukleinsäuren mittels isopsoralene
US5503721A (en) 1991-07-18 1996-04-02 Hri Research, Inc. Method for photoactivation
US6187572B1 (en) 1990-04-16 2001-02-13 Baxter International Inc. Method of inactivation of viral and bacterial blood contaminants
ATE232737T1 (de) * 1990-04-16 2003-03-15 Baxter Int Methode zur unschädlichmachung viraler und bakterieller blutverunreinigungen
US5516629A (en) 1990-04-16 1996-05-14 Cryopharm Corporation Photoinactivation of viral and bacterial blood contaminants using halogenated coumarins
US5418130A (en) 1990-04-16 1995-05-23 Cryopharm Corporation Method of inactivation of viral and bacterial blood contaminants
US5981163A (en) * 1990-05-15 1999-11-09 New York Blood Center, Inc. Process for the sterilization of biological compositions using irradiation and quenchers of type I and type II photodynamic reactions
US5712086A (en) * 1990-05-15 1998-01-27 New York Blood Center, Inc. Process for transfusing cell containing fractions sterilized with radiation and a quencher of type I and type II photodynamic reactions
US5232844A (en) * 1990-05-15 1993-08-03 New York Blood Center Photodynamic inactivation of viruses in cell-containing compositions
US5120649A (en) * 1990-05-15 1992-06-09 New York Blood Center, Inc. Photodynamic inactivation of viruses in blood cell-containing compositions
DE4136900C1 (enExample) * 1991-11-09 1993-07-29 Schaper & Bruemmer Gmbh & Co Kg, 3320 Salzgitter, De
IL104530A0 (en) * 1992-01-27 1993-05-13 Cryopharm Corp Method of inactivation of viral and bacterial blood contaminants
US5288605A (en) * 1992-03-02 1994-02-22 Steritech, Inc. Methods for inactivating bacteria in blood preparations with 8-methoxypsoralen
DE69328685T2 (de) * 1992-08-07 2000-11-23 Cerus Corp., Concord Verfahren zur inaktivierung von bakterien in blutpräparaten mit hilfe von methoxypsoralen
US6420570B1 (en) 1993-06-28 2002-07-16 Cerus Corporation Psoralen compounds
US5399719A (en) * 1993-06-28 1995-03-21 Steritech, Inc. Compounds for the photodecontamination of pathogens in blood
US5625079A (en) 1993-06-28 1997-04-29 Cerus Corporation Synthesizing psoralen compounds useful as intermediates
US6319662B1 (en) 1993-12-17 2001-11-20 Baxter International Inc. Method and apparatus for removing viral contaminants from a body fluid
AU745209B2 (en) * 1998-01-06 2002-03-14 Cerus Corporation Methods for quenching pathogen inactivators in biological materials
US6258577B1 (en) 1998-07-21 2001-07-10 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers
US7186543B1 (en) 1998-07-21 2007-03-06 Gambro Inc. Preparation of vaccines using a photosensitizer and light
US7498156B2 (en) 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US7049110B2 (en) 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
US7094378B1 (en) 2000-06-15 2006-08-22 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US7220747B2 (en) 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US6268120B1 (en) 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
TW590780B (en) 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US7648699B2 (en) 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
US7985588B2 (en) 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
EP1456359B1 (en) * 2001-12-20 2006-02-15 Gambro, Inc. Preparation of vaccines using photosensitizer and light
NL2000281C2 (nl) 2005-11-02 2007-08-07 Pfizer Prod Inc Vaste farmaceutische samenstellingen die pregabaline bevatten.
WO2025151601A1 (en) * 2024-01-09 2025-07-17 Rion Inc. Methods for reducing titer of biological contaminants in complex biologics

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6702923A (enExample) * 1966-04-06 1967-10-09
US4321919A (en) * 1979-12-11 1982-03-30 Leukocyte Research, Inc. Method and system for externally treating human blood
DE3033932C2 (de) * 1980-09-10 1984-05-24 Biotest-Serum-Institut Gmbh, 6000 Frankfurt Verfahren zur Kaltsterilisation von Blutgerinnungsfaktor VIII enthaltenden Präparaten
US4568542A (en) * 1981-06-09 1986-02-04 Lee Biomolecular Research Laboratories, Inc. Vaccine compositions

Also Published As

Publication number Publication date
JPS6016930A (ja) 1985-01-28
EP0124363B1 (en) 1990-12-19
AU563557B2 (en) 1987-07-16
EP0124363A3 (en) 1985-07-03
CA1224622A (en) 1987-07-28
AU2752184A (en) 1984-11-08
ATE59145T1 (de) 1991-01-15
ZA843270B (en) 1984-11-28
EP0124363A2 (en) 1984-11-07
DE3483751D1 (de) 1991-01-31

Similar Documents

Publication Publication Date Title
JPH0572366B2 (enExample)
US4748120A (en) Photochemical decontamination treatment of whole blood or blood components
US4727027A (en) Photochemical decontamination treatment of whole blood or blood components
CA2225470C (en) Method and apparatus for inactivating contaminants in blood products
US5342752A (en) Method of inactivation of viral blood contaminants using acridine deriatives
EP0368902B1 (en) Method for eradicating infectious contaminants in tissues
US5712086A (en) Process for transfusing cell containing fractions sterilized with radiation and a quencher of type I and type II photodynamic reactions
KR100258377B1 (ko) 생물학적 조성물의 살균 방법 및 이에 의해 생성된 생성물
Dodd et al. Inactivation of viruses in platelet suspensions that retain their in vitro characteristics: comparison of psoralen‐ultraviolet A and merocyanine 540‐visible light methods
US20020068267A1 (en) Process for the sterilization of biological compositions and the product thereby
JPS61275228A (ja) 治療用タンパク組成物中のビ−ルスの光動的不活性化
US5176921A (en) Method of blood component decontamination by glucose addition
JPH025957A (ja) 血液、血液誘導体、血漿乃至は血漿誘導体の殺菌方法
KR100630520B1 (ko) 광역-스펙트럼 펄스광을 사용하는 병원체의 불활성화 방법
Sofer Virus Inactivation in the 1990s—and into the 21st Century
Matthews et al. Preliminary studies of photoinactivation of human immunodeficiency virus in blood
CA2015315C (en) Improved method of blood component decontamination by glucose addition and post-decontamination gassing
Zhiburt Inactivation of virus in a single unit of plasma for transfusion
Olson Virus Inactivation and Removal
AuBuchon et al. Inactivation of microbial contaminants of blood components
Judy et al. Photodynamic inactivation of blood-borne enveloped viruses
Horowitz et al. Viral inactivation
Roberts Virus Safety of Cell‐derived Biological Products
Sofer Part 4, culture media, biotechnology products, and vaccines

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term